Submit abstract    

Deadline for submission of abstracts: Oct 16, 2026

Abstracts are invited by Oct 16, 2026. A selection of the best abstracts will be nominated for both oral and poster presentations. All other abstracts will be presented as poster presentations only. All accepted abstracts will be published in The Lancet Regional Health – Western Pacific.

The Summit will consider abstracts focused on haematological, breast, and gynaecological cancers as well as on cancer imaging, nuclear medicine, and theranostics across all cancer sites and types. All abstracts should be original research. We will consider clinical trials, prospective studies, retrospective analyses, meta-analyses, and observational cohort or case-control studies. However, reviews, opinion pieces, case series, or case reports will not be considered. The research should have ethics approval and clinical trials should be prospectively registered in a publicly accessible database. We also encourage registration of meta-analyses. We look forward to reading your work and welcoming you to the Summit.

To submit your abstract, please follow the instructions here.

The Summit will consider abstracts focused on the following topics:

• Clinical trials
• Original research
• Translational research
• Global oncology
• Public health
• Health policy
• AI and digital medicine

Notes for authors

All abstracts will be refereed, and a criterion of rejection will be lack of originality.

A condition of submission is that, if accepted, the paper will be presented at the conference by one of the authors. The author registration deadline is Jan 8, 2027.

Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence.